Ronald Hosking
Founder at PlantForm Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Don Stewart | M | - |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 16 years |
| Mark Goldberg | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 16 years |
| David Fraser | M | 67 |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | - |
| Bruce Clark | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 2 years |
| Michael Wanner | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 2 years |
| Grant Tipler | M | - |
Toronto Biotechnology Initiative
 Toronto Biotechnology Initiative BiotechnologyHealth Technology Toronto Biotechnology Initiative promotes growth of biotechnology. The company was founded in and is headquartered in Toronto, Canada. | - |
| Matt Buist | M | - |
Toronto Biotechnology Initiative
Toronto Biotechnology Initiative BiotechnologyHealth Technology Toronto Biotechnology Initiative promotes growth of biotechnology. The company was founded in and is headquartered in Toronto, Canada. | - |
| Anita Nador | F | - |
Toronto Biotechnology Initiative
Toronto Biotechnology Initiative BiotechnologyHealth Technology Toronto Biotechnology Initiative promotes growth of biotechnology. The company was founded in and is headquartered in Toronto, Canada. | - |
| David Cayea | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Michael Williams | M | 73 | 12 years | |
| David Hill | M | - | 8 years | |
| Nan Hutchinson | F | 62 | 2 years | |
| Ilan Oren | M | 40 | 3 years | |
| Perry B. Molinoff | M | 84 | 4 years | |
| Alan D. C. Ryley | M | - | 8 years | |
| Tomer Gold | M | 52 | 3 years | |
| Rochelle Stenzler | F | 70 | 10 years | |
| Kristen Galfetti | F | - | - | |
| Julia G. Levy | M | 89 | 5 years | |
| Tamar Howson | F | 75 | 1 years | |
| Alan Torrie | M | 73 | 7 years | |
| Gregory M. Bokar | M | 62 | - | |
| Douglas Reynolds | M | - | - | |
| Eric J. Pappert | M | - | - | |
| Jordan Dubow | M | 46 | - | |
| Stephen L. Freeman | M | 56 | - | |
| Thierry Bilbault | M | 65 | 2 years | |
| Fred Driscoll | M | 73 | - | |
| Thomas Picone | M | - | - | |
| Albert Agro | M | 59 | 6 years | |
| David Pattenden | M | - | 4 years | |
| Kenneth Hughes | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | - |
| Nathan Bryson | M | 61 | 5 years | |
| Peter Palframan | M | - | 4 years | |
| Donald J. P. Ziraldo | M | 75 | 5 years | |
| J. Hall | M | - |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 36 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald Hosking
- Personal Network
